Search

Displaying results 1141 - 1150 of 10000 in total
  1. Drug

    Fenoterol

    go.drugbank.com/drugs/DB01288
    ApprovedWithdrawn

    Fenoterol is an adrenergic beta-2 agonist that is used as a bronchodilator and tocolytic.

    Categories: Genito Urinary System and Sex Hormones, Adrenergics for Systemic UseProducts: Berotec Aem 100mcg/dose
  2. Drug

    Tiopronin

    go.drugbank.com/drugs/DB06823
    Approved

    Tiopronin may also be used to bind metal nanoparticles in Wilson's disease, which is an overload of copper in the body. … It is similar to d-penicillamine in use and efficacy, but offers the advantage of far less adverse effects.

    Categories: Genito Urinary System and Sex Hormones
  3. Drug

    Idebenone

    go.drugbank.com/drugs/DB09081
    ApprovedInvestigational

    More specifically, idebenone is thought to transfer electrons directly to complex III of the mitochondrial ETC, thereby circumventing complex I and restoring cellular energy (ATP) generation [L885]. … It is not currently approved for use by either the Food and Drug Administration (USA) or Health Canada.

  4. Drug

    Fidanacogene elaparvovec

    go.drugbank.com/drugs/DB16783
    ApprovedInvestigational

    Fidanacogene elaparvovec is a liver-specific adeno-associated virus (AAV) vector containing a codon-optimized human coagulation FIX gene that was investigated as a potential treatment for hemophilia B. … [L46691] Hemophilia B is a rare X-linked genetic disorder characterized by abnormal coagulation due to dysfunctional coagulation factor IX with a male incidence estimated to be 1 in 30,000 male births

    Categories: Complex Mixtures
  5. Drug

    Acer rubrum pollen

    go.drugbank.com/drugs/DB10475
    Approved

    Acer rubrum pollen is the pollen of the Acer rubrum plant. Acer rubrum pollen is mainly used in allergenic testing.

    Mixtures: Treatment Set TS333938, Treatment Set TS128872
  6. Drug

    Ibrutinib

    go.drugbank.com/drugs/DB09053
    ApprovedInvestigational

    November 2013 for the treatment of mantle cell lymphoma (MCL) under accelerated approval;[L12228] however, in April 2023, the drug manufacturer withdrew the accelerated approvals for ibrutinib in the US … It is designated as a targeted covalent drug and presented as a promising activity in B-cell malignancies in clinical trials.

  7. Drug

    mRNA-1345

    go.drugbank.com/drugs/DB18739
    ApprovedInvestigational

    mRESVIA was first approved in the EU and US in 2024 for use in patients 60 years of age and older. … [L53403,L52380] In June 2025, its US indication was expanded to include patients 18-59 years old at increased risk of disease.

    Categories: Complex Mixtures
  8. Drug

    Nomegestrol

    go.drugbank.com/drugs/DB11636
    Approved

    Nomegestrol is an ingredient in the EMA-authorised product Zoely.

    Categories: Genito Urinary System and Sex Hormones, Sex Hormones and Modulators of the Genital System
  9. Drug

    Natamycin

    go.drugbank.com/drugs/DB00826
    ApprovedInvestigational

    Amphoteric macrolide antifungal antibiotic from Streptomyces natalensis or S. chattanoogensis. It is used for a variety of fungal infections, mainly topically. [PubChem]

    Categories: Genito Urinary System and Sex Hormones, Antifungals for Topical Use
  10. Drug

    Betula occidentalis pollen

    go.drugbank.com/drugs/DB10832
    Approved

    Betula occidentalis pollen is the pollen of the Betula occidentalis plant. Betula occidentalis pollen is mainly used in allergenic testing.

    Mixtures: Treatment Set TS340826, Treatment Set TS341824